Skip to main content

Main menu

  • Home
  • COVID-19
    • Articles & podcasts
    • Blog posts
    • Collection
    • News
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • Classified ads
  • Authors
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
  • CMA Members
    • Overview for members
    • Earn CPD Credits
    • Print copies of CMAJ
    • Career Ad Discount
  • Subscribers
    • General information
    • View prices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN

User menu

Search

  • Advanced search
CMAJ
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN
CMAJ

Advanced Search

  • Home
  • COVID-19
    • Articles & podcasts
    • Blog posts
    • Collection
    • News
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • Classified ads
  • Authors
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
  • CMA Members
    • Overview for members
    • Earn CPD Credits
    • Print copies of CMAJ
    • Career Ad Discount
  • Subscribers
    • General information
    • View prices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
  • Visit CMAJ on Facebook
  • Follow CMAJ on Twitter
  • Follow CMAJ on Pinterest
  • Follow CMAJ on Youtube
  • Follow CMAJ on Instagram
Letters

Discontinuation of benzodiazepines

Myre Sim
CMAJ May 25, 2004 170 (11) 1645-1646; DOI: https://doi.org/10.1503/cmaj.1031869
Myre Sim
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Responses
  • Metrics
  • PDF
Loading

The article by Lucie Baillargeon and associates1 serves more to critique what is going on in medical practice than to contribute to medical knowledge. The use of benzodiazepines should be restricted to the treatment of status epilepticus;2 because of their highly addictive nature, they should not be used for habitual sedation. Even the manufacturers caution against use of benzodiazepines in elderly patients or in combination with alcohol. In a health care system that is strapped for money, it is astounding that such profligate expenditure on bad medical practice is allowed and that resources are being used to support costly withdrawal practices in a situation that should not have been initiated and supported in the first place. The publication of an article such as this one, upholstered with a sufficiency of the elegant though irrelevant algebra that so delights editors, may still do some good if it leads to action against bad medical practice and waste. Is nobody minding the shop?

Myre Sim Psychiatrist (retired) Victoria, BC

Footnotes

  • Competing interests: None declared.

References

  1. 1.↵
    Baillargeon L, Landreville P, Verreault R, Beauchemin JP, Grégoire JP, Morin CM. Discontinuation of benzodiazepines among older insomniac adults treated with cognitive-behavioural therapy combined with gradual tapering: a randomized trial. CMAJ 2003;169(10):1015-20.
    OpenUrlAbstract/FREE Full Text
  2. 2.↵
    Beers MH, Berkow R, eds. The Merck manual of diagnosis and therapy. 17th ed. Whitehouse Station (NJ): Merck and Co. Inc.; 1999. p. 1405-8.
PreviousNext
Back to top

In this issue

Canadian Medical Association Journal: 170 (11)
CMAJ
Vol. 170, Issue 11
25 May 2004
  • Table of Contents
  • Index by author

Article tools

Respond to this article
Print
Download PDF
Article Alerts
To sign up for email alerts or to access your current email alerts, enter your email address below:
Email Article

Thank you for your interest in spreading the word on CMAJ.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Discontinuation of benzodiazepines
(Your Name) has sent you a message from CMAJ
(Your Name) thought you would like to see the CMAJ web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Discontinuation of benzodiazepines
Myre Sim
CMAJ May 2004, 170 (11) 1645-1646; DOI: 10.1503/cmaj.1031869

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
‍ Request Permissions
Share
Discontinuation of benzodiazepines
Myre Sim
CMAJ May 2004, 170 (11) 1645-1646; DOI: 10.1503/cmaj.1031869
Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Footnotes
    • References
  • Responses
  • Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Highlighting obesity as a risk factor for endometrial cancer
  • Hepatitis B vaccination for Canadian children: time for an adult conversation
  • Codesigning a public health approach to preventing firearm-related suicide deaths with rural communities
Show more Letters

Similar Articles

Collections

  • Topics
    • Sleep medicine
    • Drugs: central nervous system (not psychiatric)
    • Drugs: adverse reactions

Content

  • Current issue
  • Past issues
  • Collections
  • Sections
  • Blog
  • Podcasts
  • Alerts
  • RSS
  • Early releases

Information for

  • Advertisers
  • Authors
  • Reviewers
  • CMA Members
  • Media
  • Reprint requests
  • Subscribers

About

  • General Information
  • Journal staff
  • Editorial Board
  • Governance Council
  • Journal Oversight
  • Careers
  • Contact
  • Copyright and Permissions

Copyright 2021, Joule Inc. or its licensors. All rights reserved. ISSN 1488-2329 (e) 0820-3946 (p)

All editorial matter in CMAJ represents the opinions of the authors and not necessarily those of the Canadian Medical Association or its subsidiaries.

Powered by HighWire